• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clinical Utility of On-Demand Multiplex Respiratory Pathogen Testing among Adult Outpatients

tetano

Editor, Senior Moderator
J Clin Microbiol. 2016 Sep 21. pii: JCM.01579-16. [Epub ahead of print]
[h=1]Clinical Utility of On-Demand Multiplex Respiratory Pathogen Testing among Adult Outpatients.[/h] Green DA[SUP]1[/SUP], Hitoaliaj L[SUP]2[/SUP], Kotansky B[SUP]2[/SUP], Campbell SM[SUP]1[/SUP], Peaper DR[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Multiplex tests for respiratory tract infections include up to 20 targets for common pathogens, predominantly viruses. A specific therapeutic intervention is available for those testing positive for influenza viruses (oseltamivir), and it is potentially beneficial to identify non-influenza viruses to avoid unnecessary antibiotic use. We evaluated antimicrobial prescriptions following respiratory pathogen testing among outpatients at a large Veterans Administration (VA) medical center. Results of the FilmArray Respiratory Panel (Biofire, Salt Lake City, UT) from December 15, 2014 to April 15, 2015 were evaluated among 408 outpatients, and patient medical records were reviewed. Differences in antibiotic and oseltamivir prescription rates were analyzed. Among 408 patients tested in outpatient centers (emergency department, urgent care, and outpatient clinics), 295 (72.3%) were managed as outpatients. Among these 295 outpatients, 105 (35.6%) tested positive for influenza, 109 (36.9%) tested positive for a non-influenza pathogen, and 81 (27.5%) had no respiratory pathogen detected. Rates of oseltamivir and antibiotic prescriptions were significantly different among the three test groups (Chi-squared = 167.6, p < 0.0001 and Chi-squared = 10.48, p = 0.005, respectively), but there was no significant difference in antibiotic prescription rates between the non-influenza pathogen group and those who tested negative (Chi-square = 0; p = 1.0). Among adult outpatients, testing positive for influenza was associated with receiving fewer antibiotic prescriptions, but no such effect was seen for those who tested positive for a non-influenza virus. These data suggest that testing for influenza viruses alone may be sufficient and more cost-effective than multiplex pathogen testing for outpatients.
Copyright ? 2016, American Society for Microbiology. All Rights Reserved.


PMID: 27654334 DOI: 10.1128/JCM.01579-16
[PubMed - as supplied by publisher]
 
Back
Top Bottom